# Genentech pays Alector $100M for preclinical Parkinson’s prospect

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-05 18:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Intelligence Brief
"Genentech pays Alector $100M for preclinical Parkinson’s prospect" developed substantial multi-source reporting across the Business sector, tracked across 7 distinct newsrooms by Newsylist.


Key reporting was led by BioSpace, FirstWord Pharma, WBOC TV and Stock Titan. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Genentech pays Alector $100M for preclinical Parkinson’s prospect?
Coverage spiked when 7 independent newsrooms published 7 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Key People, Organizations & Locations
Parkinson, Genentech, Alector

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioSpace | Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxNSVIwUm51RkdsMVFSTmROaG5NSGRyM3ZFUW1wRmt2TzZiaEpxejdzSHhncldxU0JDUXA1R05WbkswVkJrQlZSZU1FcGNUcTlJdnZteUQ3X2F3Vld6cFZoR0JVak14Z1R2VGUwdGdncTZ6WFJGdHBBSkYwaE5WT2xoLVFzcVNDdVRhWE4xRlZjMEd2X1JOalEtSlVFbzV0VG56X01EMm05eC16ZldMZnFLdWRRSQ?oc=5) |
| FirstWord Pharma | Roche licenses Alector's brain-penetrant Parkinson's therapy for up to $1.3B | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE1wTE04SWlicEhJbG4wZ3R1a3poVWVHSUpkVFVyQXNWV0N1RmxrUkVJQnpWOFk1dlJWbGxYNmNEenM5TWJDcmFiWDVsVFhMYWxRQXhF?oc=5) |
| WBOC TV | Biotech Brainiacs and Breakthroughs | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxNN1ZQY2dhRFB0bGFqZmEycjM2MjVkTkNLQXZhTTd0WEpSQlZyQ2RBaHhNbDdhb1ZCMnlZbE54bW9xWFdqb2lrejBoLUNCRkdjNmJYR0R2aldEbzJueXBpeC1xZ3NKYXQ4ZWMtN1RPakZucGRZOEdEd0Vtb3BETU44Z2hVRHcxMUNNQkp1MXRTZDRndmktb3ZyVXAtSkpBZUxZTm02d2xBUlcxdjJjY2c3WmF5bVNtZ05vYUhEMUtKMWFUYjd0WmhKVkpzS3NJaFZXT1pj?oc=5) |
| Stock Titan | A Parkinson’s drug deal could mean up to $1.17 billion for Alector if future goals are met. | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxNOVh1QnBsRjBGNUdQVHFzTHA2WnBBbzlpSDRlNXgyR1FrT3psd29yOVkzNE9QRk9RUHJhU2ZpSmhIRV9nTzJDaXFLZW5BNTVUSkpzczRoNHl3ZUxELWFyODJjQ2tSbjdNcHYwUk1IQ0xNTWxYdHlVWGUxX1VKY0RlSzJ2b3R6NUhXUlRReHRQUXZqV2trcGFBV1ZNcVZ5MmdvT2JNWnl0MnBTeGdSeXJxR1JWZDVvV1JmVFQ4?oc=5) |
| Yahoo Finance | Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxOcFM1WGo3R3hlX0ZLbk5QRFNseWFSc0RPYWZjeTd2WXBZRjZmRWtfRFdUTzdxM2pPT0pURXROTTBRMUlkSHRlb0Q2ZkltWWNIWXRFcnI4dW1OaG1uczVpeUZHalZmN0hMbHR5U3RLRU9odUdqOGI4Tk5lMTBKMG9MNWtNMmw1VTBzVEFLRDhHSFhlRHkzejhDeUJLV3JvUk5Od1E?oc=5) |
| reuters.com | Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxQOFIzVzd3emp4eHRpVUEtR0NSUlJnQ19ldnVlU0M5U3daYk1WRmktRy1UMTNnUWR4OFNqcktyMUR1cjR3dTJTX0trUFZhZTVjOUN3WERVMU5fcHRkaENiTk1oS3hPdFJWU21VMVQ2LU81VUVYaTVBMURIRUpXbHRyT1A1ZzFFQndNY2dmb2NQYkQtYjFIdmpQM0FxcXdKUXg5bHV5bnhzeHJjby1JNFlGdUlScnRHQQ?oc=5) |
| Fierce Biotech | Genentech pays Alector $100M for preclinical Parkinson’s prospect | 2026-10-05 14:09 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxPVTNDbklETXREYWpkYUN2RnFTVkRLRjBNaEZMM2lmSk9fSHdMcGVXYzdDX3lmR2RxV3VRNXczVXowUjJBQ2hRcHZOTENyeEt5S2F1b29FVXZxeVFOSWN6QXVCWHgtdTZ5MzY2YWhnU1hrVkhBVjNLQWZXaVNraDNmRWhqdVEtaUxwMjJXWU9Pa2FITU9jdXZGbFRKN3lMUQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-05/genentech-pays-alector-100m-for-preclinical-parkinson-s-prospect*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*